MRD / Regn No. : SG002988 Date : 25/06/2026
Patient Name : G.S.Roy Age & Gender : 68 Yrs. / Female
Contact No. : 9433828297 UHID :
Ht / Wt / BMI : 148 / 56 / 25.57 BP S / BP D : 111 / 72
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (05/Nov/1997) | CKD 3A (05/Nov/2024) | HYPERTENSION (05/Nov/2024) |
Salient Investigations : POTASSIUM: 4.17 | CREATININE: 2.07 | EGFR EGLOMERULAR FILTRATION RATE: 25.52 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 182 mg/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 6.9 % | MICROALBUMIN CREATININE RATIO: 87.3 mcg/mg
S# Generic (Trade) Name Route Dosage Usage Duration
1 CILNIDIPINE 10 MG + TELMISARTAN 80 MG
CILACAR T 80/10 MG 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
2 ATORVASTATIN 10 MG
TONACT 10 MG 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
3 TABLET FINERENONE 20 MG
LYVELSA 20 MG 		PO 1-0-0 BEFORE BREAKFAST
4 INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL 		SQ 0-0- 24 BEDTIME
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
5 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
ZEXRIDA 10 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
6 SEMAGLUTIDE 0.25 MG; 0.5 MG/DOSE)
OZEMPIC 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
7 GLICLAZIDE 80
GLIZID 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 25/Dec/2026
Tests Suggested For Next Visit : CHECK UACR:SPOT SAMPLE AND SERUM POTASSIUM AFTER 4 WEKS AND INFORM,SMBG,HBA1C-HPLC METHOD,RETINA CHECK UP,UACR:SPOT SAMPLE,CREATININE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: